Table 3. Hematological Variables.
| Variable | No Acetazolamide | Acetazolamide | F-score | p-value | ||
|---|---|---|---|---|---|---|
| No AMS | AMS | No AMS | AMS | |||
| WBC (109/L) | 6.0 ± 1.6 | 5.9 ± 1.7 | 6.0 ± 1.6 | 5.9 ± 1.8 | 0.08 | 0.97 |
| RBC (109/L) | 5.0 ± 0.4* | 4.8 ± 0.4* | 4.9 ± 0.5 | 4.9 ± 0.4 | 2.79 | 0.04 |
| Hemoglobin (g/dL) | 15.4 ± 1.2 | 15.0 ± 1.0 | 15.2 ± 1.3 | 15.3 ± 1.4 | 1.52 | 0.21 |
| Hematocrit (%) | 45.5 ± 3.4 | 44.4 ± 3.0 | 45.2 ± 3.8 | 45.5 ± 3.8 | 1.28 | 0.28 |
| Platelet (109/L) | 226. 8 ± 46.1* | 253.4 ± 54.5* | 241.9 ± 52.6 | 249.6 ± 67.9 | 3.13 | 0.03 |
| MCV (μg/cell) | 91.8 ± 4.1 | 93.5 ± 3.8 | 93.2 ± 5.1 | 92.3 ± 5.4 | 1.84 | 0.14 |
| MCH (μg/cell) | 31.0 ± 1.3 | 31.5 ± 0.9 | 31.5 ± 1.2 | 30.9 ± 1.6 | 2.76 | 0.04 |
| MCHC (μg/cell) | 33.8 ± 0.8 | 33.7 ± 0.9 | 33.6 ± 1.1 | 33.5 ± 1.1 | 0.93 | 0.43 |
| RDW (%) | 13.7 ± 1.0* | 13.3 ± 0.8Ω | 13.6 ± 0.9 | 14.2 ± 1.5*Ω | 6.25 | <0.01 |
| Eosinophils (109/L) | 2.2 ± 1.8 | 2.5 ± 1.9 | 2.3 ± 1.9 | 2.4 ± 2.3 | 0.22 | 0.89 |
| Estimated Change in Plasma Volume (%) | -7.2 ± 11.1 | -7.5 ± 11.9 | -4.6 ± 13.2 | -6.1 ± 13.3 | 0.51 | 0.67 |
| Iron (μg/dL) | 112.5 ± 38.8 | 127.3 ± 51.8 | 122.4 ± 41.2 | 109.5 ± 45.9 | 1.93 | 0.13 |
| Iron Saturation (%) | 35.9 ± 14.0 | 39.6 ± 14.9 | 39.8 ±15.8 | 34.6 ± 15.7 | 1.57 | 0.20 |
| TIBC (μg/dL) | 323.0 ± 45.1 | 321.6 ± 40.6 | 316.9 ± 52.4 | 326.6 ± 49.1 | 0.34 | 0.79 |
| UIBC (μg/dL) | 210.2 ± 59.4 | 195.9 ± 55.3 | 195.3 ± 65.5 | 216.0 ± 76.2 | 1.23 | 0.30 |
*, Ω—indicates significant differences, p<0.05; Degrees of freedom = 3